If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: -0.25 (-3.28%)
Spread: 0.25 (3.448%)
Open: 7.625
High: 7.625
Low: 7.375
Prev. Close: 7.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Ixico revenue falls, Solid State boosts profit

Tue, 05th Dec 2023 14:31

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Ixico PLC - London-based precision analytics company working to advance investigational therapies for neurological diseases - Revenue for the year that ended on September 30 falls 23% to GBP6.7 million from GBP8.6 million the year before. Company swings to GBP1.4 million pretax loss following a GBP885,000 profit. Total operating expenses increase to GBP5.1 million from GBP5.0 million. Ixico says revenue drop was expected and caused by the now-realised impact of clients ceasing multiple large "failed" trials across 2021 and early 2022. Expects to deliver roughly flat revenue in the current financial year before returning to growth in 2025.

----------

Supply@Me Capital PLC - London-based fintech platform provider - Says it has so far received GBP1.4 million from The AvantGarde Group SpA as a result of contractual payments. An additional GBP1.5 million remains outstanding. Also says it has made significant progress in the formalisation of its first White-Label IM agreement with an Italian banking group with a transaction valued at up to EUR10 million. Company is also working to finalise a framework to issue security tokens up to USD100 million to be subscribed in tranches.

----------

Lindsell Train Investment Trust PLC - London-based, rail-focused investment trust - Net asset value at September 30 is GBP968.75 per share, down from GBP1,056.95 at March 31. NAV total return for the six months to September 30 is negative 3.6%, underperforming the MSCI World Index with positive 4.5%. Says performance was impacted by high interest rates and inflation, and believes it may have to reduce its dividend. Notes reduced investor risk appetites and increased market volatility.

----------

Marechale Capital PLC - London-based corporate finance adviser - Revenue for the half year that ended on October 31 increased 91% to GBP320,603 from GBP168,001. Cost of sales more than doubles to GBP226,790 from GBP95,981. Pretax loss narrows to GBP155,803 from GBP179,502. Marechale says market is still challenging, especially in the hospitality sector, but that it remains positive about the outlook for its investments.

----------

Anglesey Mining PLC - Base metals miner with operations in North Wales, Sweden and Canada - Says drilling of the NCZ001 hole in the Northern Copper Zone at its Parys Mountain project on the Isle of Anglesey commenced on October 27, and is expected to complete over the next week. Expects results in the first quarter of 2024. Says initial logging suggests sulphide mineralisation commencing at around 350 metres deep. Chief Executive Jo Battershill says initial core is "very encouraging" as "we are seeing a significant amount of quartz veins within the system..[which] contain encouraging amounts of chalcopyrite, sphalerite, and galena – the key minerals that host copper, zinc and lead."

----------

Psych Capital PLC - London-based psychedelic medicines media firm and investor - Oscillate PLC continues to own 46.0 million shares in Psych, representing 12.75% of its issued share capital, following Psych's acquisition of Short Wave Pharma Inc which completed in November. Oscillate says it will continue to assess the investment to ascertain an exit opportunity. Says it meanwhile remains "optimistic at the advances that the Short Wave acquisition represents in the innovative psychedelics space." Oscillate also says that trials are due to start in the first quarter of 2024.

----------

Solid State PLC - Redditch, England-based supplier & design-in manufacturer of computing, power, and communications products - Pretax profit for the six months to September 30 is GBP6.1 million, up 45% from GBP4.2 million the prior year. Revenue increases 48% to GBP88.1 million from GBP59.4 million. Company declares 7.0 pence per share interim dividend, up 8% from 6.5p the year before. Says it is confident in meeting expectations for full-year results thanks to "record billings" and a "stable six-month order book". Open order book at October 31 stood at GBP108.6 million, slightly down from GBP112.5 million at September 30, 2022.

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Mar 2014 09:19

Thursday broker round-up UPDATE

Antofagasta: Deutsche Bank cuts target price from 770p to 735p and downgrades to sell. Investec cuts target price from 753p to 726p keeping its sell recommendation. Ashmore Group: HSBC Holdings lowers target price from 410p to 400p retaining its overweight rating. Avacta Group: Numis shifts target

Read more
11 Mar 2014 15:45

Standard Chartered non-exec builds company holding after profit decline

An Independent Non-Executive Director of Standard Chartered has this week upped his stake in the group by a quarter with the purchase of 2,500 shares. John Paynter, who was appointed to his role in 2008, bought the shares at 1,246.50p each for a total of £31,163, taking his total holding to 12,50

Read more
11 Mar 2014 15:07

DIRECTOR DEALINGS: Ixico Non-Executives Buy Shares

LONDON (Alliance News) - Ixico PLC said Tuesday that non-executive chairman Andy Richards had bought 13,700 shares at 78 pence each. Non-executive director Tim Sharpington bought 12,750 shares at 78.5 pence also on Tuesday. Following these purchases Richards has a 0.2% interest in the

Read more
7 Mar 2014 14:47

IXICO, VirtualScopics In International Commercial, Operational Alliance

LONDON (Alliance News) - Brain health company IXICO PLC Friday said it has entered into an international commercial and operational alliance with VirtualScopics Inc, a quantitative medical imaging provider. "The proposed alliance will provide the clinical trials industry with global operati

Read more
28 Feb 2014 15:59

IXICO Positive On Position Following Business Transition

LONDON (Alliance News) - IXICO PLC, the company formed when IXICO Ltd and Phytopharm PLC merged, said Friday that it believes it is strongly positioned in its core clinical trials and experimental medicine markets following the transition of its business. The company formally known as Phyto

Read more
18 Nov 2013 18:34

DIRECTOR DEALINGS: IXICO Non-Executive Director Buys Shares

Read more
18 Nov 2013 18:27

IXICO Non-Executive Director Buys Shares

Read more
1 Nov 2013 16:47

DIRECTOR DEALINGS: Ixico Executive Buys Shares

Read more
31 Oct 2013 14:05

DIRECTOR DEALINGS: IXICO CEO Buys 4,000 Shares

Read more
21 Oct 2013 12:45

DIRECTOR DEALINGS: IXICO Chairman Buys Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.